-+ 0.00%
-+ 0.00%
-+ 0.00%

ADIAL APPLAUDS CONGRESSIONAL DIRECTIVE ADVANCING ALTERNATIVE CLINICAL TRIAL ENDPOINTS FOR SUBSTANCE USE DISORDERS, STRENGTHENING REGULATORY PATH FOR AD04

Reuters·02/04/2026 14:35:00

Please log in to view news